MANFREDI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 494
EU - Europa 141
AS - Asia 109
AF - Africa 5
OC - Oceania 2
Totale 751
Nazione #
US - Stati Uniti d'America 494
CN - Cina 88
GB - Regno Unito 61
DE - Germania 24
SE - Svezia 20
FI - Finlandia 12
SG - Singapore 9
TR - Turchia 6
AL - Albania 5
CI - Costa d'Avorio 5
CZ - Repubblica Ceca 4
IE - Irlanda 4
JP - Giappone 4
RU - Federazione Russa 4
UA - Ucraina 3
AU - Australia 2
IN - India 2
NL - Olanda 2
FR - Francia 1
IT - Italia 1
Totale 751
Città #
Fairfield 93
Woodbridge 75
Southend 58
Ashburn 46
Seattle 37
Cambridge 32
Chandler 31
Wilmington 29
Houston 28
Ann Arbor 24
Dearborn 21
Nanjing 15
Boardman 12
Beijing 11
Jacksonville 9
Shenyang 9
Jinan 8
Helsinki 7
Shanghai 7
Izmir 6
Kunming 5
Princeton 5
Singapore 5
Brno 4
Dublin 4
San Diego 4
Tokyo 4
Changsha 3
Hangzhou 3
Hebei 3
Jiaxing 3
Plano 3
Redwood City 3
Zhengzhou 3
Dallas 2
Fort Worth 2
Hefei 2
Nanchang 2
Pune 2
Taiyuan 2
Taizhou 2
Tianjin 2
Groningen 1
Haikou 1
Kilburn 1
London 1
Los Angeles 1
Munich 1
New Bedfont 1
Norwalk 1
Totale 634
Nome #
The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIX(TM) Adjuvant 171
The Contribution of Extracellular Nef to HIV-Induced Pathogenesis 152
Uncovering the role of defective HIV-1 in spreading viral infection 151
Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1 146
HPV-E7 delivered by engineered exosomes elicits a protective CD8+ T cell-mediated immune response 139
Totale 759
Categoria #
all - tutte 2.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020189 0 0 0 0 30 35 32 26 43 12 3 8
2020/202188 3 7 3 10 9 3 18 12 5 8 5 5
2021/202253 6 0 8 0 11 2 0 3 5 2 3 13
2022/202380 12 21 3 5 5 15 0 3 4 0 6 6
2023/202453 3 1 3 3 2 6 10 11 1 1 0 12
2024/202522 4 4 14 0 0 0 0 0 0 0 0 0
Totale 759